Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators

Malaria ranks among the most important infectious diseases worldwide and affects mostly people living in tropical countries. Mechanisms involved in disease progression are still not fully understood and specific treatments that might interfere with cerebral malaria (CM) are limited. Here we show tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Kim E., Kuepper, Janina M., Schumak, Beatrix, Alferink, Judith, Hofmann, Andrea, Howland, Shanshan W., Rénia, Laurent, Limmer, Andreas, Specht, Sabine, Hoerauf, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811026/
https://www.ncbi.nlm.nih.gov/pubmed/29438386
http://dx.doi.org/10.1371/journal.pone.0192717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811026/
https://www.ncbi.nlm.nih.gov/pubmed/29438386
http://dx.doi.org/10.1371/journal.pone.0192717

Ejemplares similares